{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:54:17Z","timestamp":1787313257003,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.psychres.2022.114499","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T15:42:22Z","timestamp":1646667742000},"page":"114499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Pharmacotherapy of impulse control disorders: A systematic review"],"prefix":"10.1016","volume":"311","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-3704","authenticated-orcid":false,"given":"Talha","family":"Tahir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie Mitsui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Maaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Naufal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yedishtra","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2022.114499_bib0001","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2013a. Disruptive, Impulse-Control, and Conduct Disorders. Diagnostic and Statistical Manual of Mental Disorders 5th ed. https:\/\/doi.org\/10.1176\/APPI.BOOKS.9780890425596.DSM15.","DOI":"10.1176\/appi.books.9780890425596.dsm15"},{"key":"10.1016\/j.psychres.2022.114499_bib0002","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2013b. Diagnostic and Statistical Manual of Mental Disorders. https:\/\/doi.org\/10.1176\/APPI.BOOKS.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.psychres.2022.114499_bib0003","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2000"},{"issue":"6","key":"10.1016\/j.psychres.2022.114499_bib0004","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/cap.2006.16.665","article-title":"The Efficacy and Tolerability of Quetiapine versus Divalproex for the Treatment of Impulsivity and Reactive Aggression in Adolescents with Co-Occurring Bipolar Disorder and Disruptive Behavior Disorder(s)","volume":"16","author":"Barzman","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114499_bib0005","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jpsychires.2020.01.007","article-title":"The Overt Aggression Scale Modified (OAS-M) for clinical trials targeting impulsive aggression and intermittent explosive disorder: validity, reliability, and correlates","volume":"124","author":"Coccaro","year":"2020","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.psychres.2022.114499_bib0006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.2012.11081259","article-title":"Intermittent Explosive Disorder as a Disorder of Impulsive Aggression for DSM-5","volume":"169","author":"Coccaro","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0007","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.psychres.2015.07.078","article-title":"Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder","volume":"229","author":"Coccaro","year":"2015","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.psychres.2022.114499_bib0008","doi-asserted-by":"crossref","first-page":"e2714","DOI":"10.1002\/hup.2714","article-title":"5-HT2c agonist, lorcaserin, reduces aggressive responding in intermittent explosive disorder: a pilot study","volume":"34","author":"Coccaro","year":"2019","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.psychres.2022.114499_bib0009","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4088\/JCP.08m04150","article-title":"A Double-Blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Patients with Intermittent Explosive Disorder","volume":"70","author":"Coccaro","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0010","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1176\/appi.ajp.157.5.818","article-title":"Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design","volume":"157","author":"Donovan","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0011","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/npp.2015.153","article-title":"Impulsivity and Aggression in Female BPD and ADHD Patients: association with ACC Glutamate and GABA Concentrations","volume":"41","author":"Ende","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.psychres.2022.114499_bib0012","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1176\/ajp.148.8.986","article-title":"Kleptomania: making sense of the nonsensical","volume":"148","author":"Goldman","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0013","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0014","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.biopsych.2008.11.022","article-title":"A Double-Blind, Placebo-Controlled Study of the Opiate Antagonist, Naltrexone, in the Treatment of Kleptomania","volume":"65","author":"Grant","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4088\/JCP.v62n0311","article-title":"A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder","volume":"62","author":"Hollander","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0016","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/appi.ajp.162.3.621","article-title":"Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder","volume":"162","author":"Hollander","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0017","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/sj.npp.1300153","article-title":"Divalproex in the Treatment of Impulsive Aggression: efficacy in Cluster B Personality Disorders","volume":"28","author":"Hollander","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.psychres.2022.114499_bib0018","article-title":"Pharmacological interventions for antisocial personality disorder","volume":"9","author":"Khalifa","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.psychres.2022.114499_bib0019","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4088\/JCP.v68n0311","article-title":"Escitalopram Treatment of Kleptomania: an Open-Label Trial Followed by Double-Blind Discontinuation","volume":"68","author":"Koran","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/pcn.12940","article-title":"Prefrontal GABA and glutamate levels correlate with impulsivity and cognitive function of prescription opioid addicts: a 1H-magnetic resonance spectroscopy study","volume":"74","author":"Li","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2022.114499_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.psychres.2022.114499_bib0022","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00213-006-0559-0","article-title":"Relationship between limbic and cortical 5-HT neurotransmission and acquisition and reversal learning in a go\/no-go task in rats","volume":"189","author":"Masaki","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"issue":"2","key":"10.1016\/j.psychres.2022.114499_bib0023","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4088\/JCP.v69n0218","article-title":"Levetiracetam in Patients With Impulsive Aggression: a Double-Blind, Placebo-Controlled Trial","volume":"69","author":"Mattes","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0024","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.jcp.0000186739.22395.6b","article-title":"Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial","volume":"25","author":"Mattes","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2022.114499_bib0025","unstructured":"National Comorbidity Survey: Adolescent Supplement (NCS-A), 2001 -2004 [WWW Document], n.d. URL https:\/\/www.icpsr.umich.edu\/web\/HMCA\/studies\/28581 (accessed 9.14.21)."},{"issue":"2","key":"10.1016\/j.psychres.2022.114499_bib0026","article-title":"Impulse-Control Disorders in a College Sample: results From the Self-Administered Minnesota Impulse Disorders Interview (MIDI). The Primary Care Companion","volume":"12","author":"Odlaug","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2022.114499_bib0027","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674371506000203","volume":"60","author":"Pringsheim","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114499_bib0028","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2022.114499_bib0029","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.npp.1300434","article-title":"Fractionating Impulsivity: contrasting Effects of Central 5-HT Depletion on Different Measures of Impulsive Behavior","volume":"29","author":"Winstanley","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2022.114499_bib0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00213-004-1884-9","article-title":"5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion","volume":"176","author":"Winstanley","year":"2004","journal-title":"Psychopharmacology (Berl.)"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122001135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122001135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:54:23Z","timestamp":1759038863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122001135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"alternative-id":["S0165178122001135"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114499","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacotherapy of impulse control disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114499"}}